S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

NDRA ENDRA Life Sciences Inc

0.29

0.0071 (2.51%)

After Hours

Last Updated: 16:47:56

Delayed by 15 minutes

Endra Life Sciences EPS beats by $0.01

To read the full story on Seeking Alpha, click here.

ENDRA Life Sciences (NASDAQ:NDRA)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more ENDRA Life Sciences Charts.

ENDRA Life Sciences (NASDAQ:NDRA)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more ENDRA Life Sciences Charts.

ENDRA Life Sciences Inc News

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Thursday 28 March 2024 (1 month ago) • Business Wire

ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024
Thursday 21 March 2024 (1 month ago) • Business Wire

ENDRA Life Sciences Installs First TAEUS System in the UK
Tuesday 27 February 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Friday 23 February 2024 (2 months ago) • Edgar (US Regulatory)

New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System
Wednesday 21 February 2024 (2 months ago) • Business Wire

ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe
Wednesday 14 February 2024 (3 months ago) • Business Wire

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 29 December 2023 (4 months ago) • Edgar (US Regulatory)

ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology
Wednesday 29 November 2023 (5 months ago) • Business Wire

ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference
Monday 27 November 2023 (5 months ago) • Business Wire

ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
Tuesday 14 November 2023 (6 months ago) • Business Wire

Form 8-K - Current report
Tuesday 14 November 2023 (6 months ago) • Edgar (US Regulatory)

ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents
Wednesday 8 November 2023 (6 months ago) • Business Wire

More ENDRA Life Sciences Inc News Articles

Global Developments (PK)

NaturalShrimp (QB)

Mullen Automotive

FBEC Worldwide (PK)

Tonner One World (PK)

Wanderport (PK)

Fannie Mae (QB)

NioCorp Developments

Branded Legacy (PK)

International Star (PK)

Moon Equity (PK)

Virexit Technologies (PK)

Impact Fusion (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions